These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 20469588

  • 1. [Neurobiological mechanisms of depression and antidepressant therapy].
    Shishkina GT, Dygalo NN.
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2010; 60(2):138-52. PubMed ID: 20469588
    [Abstract] [Full Text] [Related]

  • 2. New approaches to antidepressant drug discovery: beyond monoamines.
    Berton O, Nestler EJ.
    Nat Rev Neurosci; 2006 Feb; 7(2):137-51. PubMed ID: 16429123
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. New drug targets in the signaling pathways activated by antidepressants.
    Páez-Pereda M.
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):1010-6. PubMed ID: 15946780
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [The neuroendocrinology of stress and the pathophysiology and therapy of depression and anxiety].
    Ströhle A.
    Nervenarzt; 2003 Mar; 74(3):279-91; quiz 292. PubMed ID: 12627245
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Advances in the molecular treatment of depression].
    Páez X, Hernández L, Baptista T.
    Rev Neurol; 2003 Mar; 37(5):459-70. PubMed ID: 14533097
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Stress responsive neurohormones in depression and anxiety.
    Ströhle A, Holsboer F.
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S207-14. PubMed ID: 14677081
    [Abstract] [Full Text] [Related]

  • 15. The hippocampus, neurotrophic factors and depression: possible implications for the pharmacotherapy of depression.
    Masi G, Brovedani P.
    CNS Drugs; 2011 Nov 01; 25(11):913-31. PubMed ID: 22054117
    [Abstract] [Full Text] [Related]

  • 16. Does neurotropin-3 have a therapeutic implication in major depression?
    Pae CU, Marks DM, Han C, Patkar AA, Steffens D.
    Int J Neurosci; 2008 Nov 01; 118(11):1515-22. PubMed ID: 18853330
    [Abstract] [Full Text] [Related]

  • 17. The role of monoamines in the actions of established and "novel" antidepressant agents: a critical review.
    Millan MJ.
    Eur J Pharmacol; 2004 Oct 01; 500(1-3):371-84. PubMed ID: 15464046
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic and endocrine mechanisms.
    Bschor T, Lewitzka U, Sasse J, Adli M, Köberle U, Bauer M.
    Pharmacopsychiatry; 2003 Nov 01; 36 Suppl 3():S230-4. PubMed ID: 14677084
    [Abstract] [Full Text] [Related]

  • 20. [Pathophysiology of depression].
    Tanabe A, Nomura S.
    Nihon Rinsho; 2007 Sep 01; 65(9):1585-90. PubMed ID: 17876979
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.